Non-lethal fetal toxicity of the angiotensin receptor blocker candesartan [2]

Pediatric Nephrology

Volumn 21, Issue 9, 2006, Pages 1329-1330

  Simonetti, Giacomo D ^a   Baumann, Thomas ^b   Pachlopnik, Jana M ^a   von Vigier, Rodo O ^a   Bianchetti, Mario G ^a,c,d,e  

^a UNIVERSITY OF BERN   (Switzerland)

^b Ospedale San Giovanni ^*  (Switzerland)

^c OSPEDALE SAN GIOVANNI   (Switzerland)

^d Ospedale Beata Vergine   (Switzerland)

^e Clinica Pediatrica De Marchi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; LUNG SURFACTANT; OXYGEN;

ADULT; ARTIFICIAL VENTILATION; BONE MALFORMATION; CALVARIA; CASE REPORT; CESAREAN SECTION; CHILDBIRTH; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; ESSENTIAL HYPERTENSION; FEMALE; FETOTOXICITY; FETUS; HEAD CIRCUMFERENCE; HUMAN; HYPOPLASIA; HYPOTENSION; LANGUAGE DISABILITY; LETHALITY; LETTER; LIMB DISEASE; MALE; MATERNAL HYPERTENSION; MICROCEPHALY; OLIGURIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SKULL DISEASE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; CHILD, PRESCHOOL; CONTRACTURE; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MICROCEPHALY; PREGNANCY; TETRAZOLES;

EID: 33746957837     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0162-y     Document Type: Letter

References (6)

1. Hilgers KF, Dötsch J, Rascher W, Mann JF (2004) Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol 19:956-961
2. Volpe M, Ruilope LM, McInnes GT, Waeber B, Weber MA (2005) Angiotensin-II receptor blockers: Benefits beyond blood pressure reduction? J Hum Hypertens 19:331-339
3. Alwan S, Polifka JE, Friedman JM (2005) Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res, Clin Mol Teratol 73:123 (Addendum in: Birth Defects Res, Clin Mol Teratol 73:904-905)
4. Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23-28
5. Bönner G, Fuchs W (2005) Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension. Curr Med Res Opin 21:935-940
6. Sedman AB, Kershaw DB, Bunchman TE (1995) Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol 9:382-385